Hypertrophic cardiomyopathy (HCM) presents with a wide spectrum of heterogeneous morphology. Modalities used to assess HCM include echocardiography, cardiac catheterization, radionuclide angiography, conventional computed tomography (CT), and magnetic resonance imaging. This investigation was performed to assess the feasibility of using ultrafast CT with 50 ms/scan acquisition time in the cine mode to compare 11 patients with HCM to 11 patients with normal studies. A specific advantage of this technique includes tomographic representation of ventricular anatomy coupled with the ability to evaluate multiple parameters of dynamic function. Global and tomographic ejection fraction, left ventricular mass, wall thickness, left atrial size, and diastolic filling rates are among the parameters that can be measured. Mitral valve motion can also be assessed. Comparisons were made between the HCM and normal groups using a sample t test. There was a significant difference in left ventricular mass (p < 0.05) between the groups. Specific wall thickness parameters were also measured. Comparisons of the septal basal, septal mid-left ventricular, anterior basal, anterior mid-left ventricular, lateral, and posterior walls revealed a significant difference (p < 0.05). The left atrial dimensions also demonstrated a significant difference (p < 0.05). Quantitative assessment of HCM can be performed by ultrafast CT. The combination of excellent spatial and temporal resolution makes it competitive and potentially superior to other techniques. Ultrafast CT should be considered when confronted with the need for diagnostic evaluation and subsequent follow-up in HCM.

Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.